Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott molecular Chlamydia test receives EU certification

Abbott molecular Chlamydia test receives EU certification

18th January 2008

A newly-developed molecular test able to identify a variant strain of Chlamydia has received CE Mark certification in the European Union (EU), it was announced this week.

The assay was formulated after Swedish health authorities noted a 25 per cent decrease in Chlamydia infections during 2006 and suspected a variant strain may be causing false-negative results.

It is intended for use with the Abbott m2000 system, which uses real-time polymerase chain reaction technology to detect the plasmid DNA for Chlamydia trachomatis in urethral, vaginal or endocervical swab specimens.

Laboratories across the EU will now have access to the test. Although the variant strain has been mostly limited to Sweden, other isolated cases have been reported and it is thought international travel will cause it to spread.

Dr Torvald Ripa, assistant professor at the department of clinical microbiology and infection control in Sweden’s Halmstad hospital, said Abbott responded “fast” to the need for such a test.

“By March 2007, we were double testing some 1,200 samples with the new research kit,” he added.

If left untreated, Chlamydia can lead to pelvic inflammatory disease in women, which may lead to ectopic pregnancy, infertility or miscarriage.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.